Both arsenic compounds upregulate expression levels of antiapoptotic genes BCL2 and BCL2L1 and downregulate expression levels of proapoptotic genes CASP8 and CASP9, promoting apoptosis in breast cancer cells. Here, BCL2 is linked to breast cancer.